For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Alto Neuroscience Inc (NYSE: ANRO) closed at $17.8 in the last session, down -0.78% from day before closing price of $17.94. In other words, the price has decreased by -$0.78 from its previous closing price. On the day, 0.2 million shares were traded. ANRO stock price reached its highest trading level at $18.3099 during the session, while it also had its lowest trading level at $17.69.
Ratios:
We take a closer look at ANRO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.42 and its Current Ratio is at 15.42. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.24.
On September 29, 2025, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $15.
Wedbush Downgraded its Outperform to Neutral on October 23, 2024, whereas the target price for the stock was revised from $29 to $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANRO now has a Market Capitalization of 552980736 and an Enterprise Value of 440562752.
Stock Price History:
The Beta on a monthly basis for ANRO is 2.93, which has changed by 3.0958905 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, ANRO has reached a high of $20.91, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is 23.68%, while the 200-Day Moving Average is calculated to be 198.86%.
Shares Statistics:
According to the various share statistics, ANRO traded on average about 1.73M shares per day over the past 3-months and 519960 shares per day over the past 10 days. A total of 31.07M shares are outstanding, with a floating share count of 27.85M. Insiders hold about 10.34% of the company’s shares, while institutions hold 69.32% stake in the company. Shares short for ANRO as of 1765756800 were 2781726 with a Short Ratio of 1.60, compared to 1763078400 on 2810725. Therefore, it implies a Short% of Shares Outstanding of 2781726 and a Short% of Float of 10.99.
Earnings Estimates
At present, 3 analysts are actively evaluating the performance of Alto Neuroscience Inc (ANRO) in the stock market.The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.41 and low estimates of -$0.56. Analysts are recommending an EPS of between -$2.35 and -$2.35 for the fiscal current year, implying an average EPS of -$2.35. EPS for the following year is -$2.13, with 3.0 analysts recommending between -$1.7 and -$2.4.
